Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

Tekla Healthcare Opportunities Fund  as of 06/15/2021

NYSE / THQ Asset Class:  Sector Equity Funds 1 YR Lipper Avg:  37.62%

Growth of $10K

Avg Annual Total Return %
  10 YR 5 YR 1 YR YTD
Market Return -- 16.04% 43.54% 18.77%
Lipper Pct. Rank -- 22 50 39
NAV Return -- 12.81% 29.50% 11.93%
Lipper Pct. Rank -- 39 57 35
Premium/Discount History

10 YR Avg 5 YR Avg YTD Avg
-- -8.967% -4.440%

NAV $23.73 Market Price $23.59
Net Change -$0.05 Market Change -$0.04
Premium/Discount -0.59%
1 YR NAV Return 29.504%
1 YR NAV Rank 57
12-Mo Yield as of 4/30/2021 Yield Def
Income Only Yield 0.63%
Distribution Yield (Market) 5.73%
Most Recent Income Dividend $0.113
Ex-Div Date 5/19/2021
Most Recent Cap Gain Dividend $0.044
Ex-Div Date 12/19/2019
Dividend Frequency Monthly
YTD Dividends $0.450
YTD Capital Gains --
Inception Date 7/31/2014
Fund Advisor Tekla Capital Management LLC
Manager & Tenure Team Managed
Phone 800-426-5523
Total Net Assets (mil) as of 5/31/2021 $971.5
% Leveraged Assets as of 9/30/2020 21.84%
Portfolio Turnover 59.00%
Mgmt Fees 1.279%
Expense Ratio 2.050%
Fund Objective
The Fund seeks current income and long-term capital appreciation. Under normal market conditions, the Trust expects to invest at least 80% of its Managed Assets in U.S. and non-U.S. companies engaged in the healthcare industry including equity securities, debt securities, and pooled investment vehicles.
Top Holdings (as of 12/31/2020)
Johnson & Johnson ORD 6.44%
UnitedHealth Group Inc ORD 6.12%
Thermo Fisher Scientific Inc ORD 4.47%
Abbvie Inc ORD 4.26%
Medtronic PLC ORD 4.19%
Abbott Laboratories ORD 3.90%
Danaher Corp ORD 3.70%
Bristol-Myers Squibb Co ORD 3.66%
Merck & Co Inc ORD 3.25%
Eli Lilly and Co ORD 2.65%
Top Sectors (as of 12/31/2020)
Health Care 86.47%
Industrials 6.53%
Financials 6.30%
Consumer Services 2.60%
Non Classified Equity 1.43%
Technology 0.00%

Closed-End Funds Mid-year Review 

Axel Merk and Peter Maletis of Merk Investments discuss their outlook and insights on Gold, Precious Metals and Mining for investors concerned about inflation or seeking diversification.


The views and opinions expressed in the replay are for informational and educational purposes only as of the date of production/writing and may change without notice at any time based on factors such as market conditions or legal and regulatory developments. This material may contain “forward-looking” information that is not purely historical in nature. Such information may include, among other things, projections, forecasts, estimates of market returns, and proposed or expected portfolio composition. Past performance is no guarantee of future results. Investing involves risk; principal loss is possible. This material is not intended to be a recommendation or investment advice, does not constitute a solicitation to buy, sell or hold a security or an investment strategy, and is not provided in a fiduciary capacity. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. Closed-end funds frequently trade at a discount to their net asset value (NAV).


Dennis Emanuel
Director ETF & CEF Strategy

Dave Lamb
Managing Director in the Global Products Group

Jonathan Isaac 
Director of Product Management



Aberdeen Closed-End TV

Asset TV — CEF Channel

CEF Connect

Cohen & Steers CEFs Knowledge Center

Harvest — CEFA Channel

Legg Mason CEFs

Seeking Alpha — CEFA Channel

SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

© Thomson Reuters 2019. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.